The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India
The global burden of NAFLD (Now Referred to as MASLD) -related disease is shaped by multifaceted factors-population aging, evolving epidemiologic dynamics, and socioeconomic disparities. While some regions exhibit declining DALYs and mortality, others (notably India and the US) face escalating burdens. Addressing these challenges necessitates tailored public health strategies that reflect distinct regional patterns. Implementing targeted interventions is imperative to mitigate health inequities and enhance global health outcomes.
Authors
- Changhao Gu
- Jingyu Zeng (ORCID: https://orcid.org/0000-0002-5892-6098)
- Chenchen Shen (ORCID: https://orcid.org/0000-0003-1244-8526)
- Congle Wen
Institutions
- Wenzhou Hospital of Traditional Chinese Medicine (CN)
- Tang Hospital (CN)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s12944-025-02750-z
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42